Active Litigation
Zantac Cancer Lawsuit
Nationwide Representation - Ranitidine Recalled Over NDMA, a Probable Human Carcinogen
Zantac and NDMA Contamination
Zantac (ranitidine) was recalled worldwide after testing found that the popular heartburn medication could contain NDMA, which health agencies classify as a probable human carcinogen. Millions of people who took Zantac may have been exposed to elevated levels of NDMA.
Understanding Zantac Cancer Risks
NDMA Contamination
Zantac contained N-Nitrosodimethylamine (NDMA), which health agencies classify as a probable human carcinogen.
Widespread Use
Zantac was one of the most popular over-the-counter and prescription heartburn medications for decades.
Global Recall
The FDA and health authorities worldwide recalled Zantac products due to NDMA contamination concerns.
Do You Qualify for a Zantac Lawsuit?
Zantac Use
You regularly took Zantac (ranitidine) for heartburn, acid reflux, or other stomach conditions.
Cancer Diagnosis
You were diagnosed with stomach, bladder, liver, kidney, or other cancers linked to NDMA exposure.
Duration of Use
You used Zantac for an extended period, increasing your exposure to NDMA contamination.
Timeline
Your cancer diagnosis occurred after taking Zantac products containing NDMA.
Frequently Asked Questions
Questions about ranitidine and NDMA claims
Does a worldwide recall mean everyone who took Zantac has a case?
+No. Claims still depend on use, timing, and a qualifying diagnosis. The recall is evidence of a contamination problem, not automatic compensation.
What if I took generic ranitidine?
+Generic use can still matter. Tell the reviewer every ranitidine product you remember, including store brands.
Do I need the original bottles?
+Helpful if you have them. Pharmacy records, medical notes, and insurance claims can also show use.
Take Action
Ready to Discuss Your Case?
Get your free case review today. No obligations, no upfront costs.